Published in Drug Week, January 7th, 2005
Anticoagulation therapies, or treatments that reduce the amount of clotting factors in the blood, are quite common and used for a variety of reasons.
The first abstract presented was entitled, "Enoxaparin is Effective and Safe as Bridging Anticoagulation in Patients with a Mechanical Prosthetic Heart Valve Who Require Temporary Interruption of Warfarin Because of Surgery or an Invasive Procedure."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.